Author:
Weeda Erin R.,Cassarly Christy,Brinton Daniel L.,Shirley David W.,Simpson Kit N.
Funder
National Center for Advancing Translational Sciences
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference39 articles.
1. Role of diabetes in congestive heart failure: the Framingham study;Kannel;Am J Cardiol,1974
2. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015
3. Canagliflozin and cardiovascular and renal events in type 2 diabetes;Neal;N Engl JMed,2017
4. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med. 380.,2019
5. Boehringer Ingelheim. EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced). Available from: https://www.dovepress.com/author_guidelines.php?content_id=2967
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献